← Back to the report

IOI Corporation Berhad

Consumer Defensive · Generated 9 April 2026

IOI Corporation Berhad (1961.KL) - Deep Dive Research Report

Prepared: April 2026 | Sector: Consumer Defensive (Integrated Palm Oil) | Exchange: Bursa Malaysia Main Market


1. What the Company Does

IOI Corporation Berhad is a Malaysian integrated palm oil company. It grows oil palms, processes the fruit into crude palm oil (CPO) and palm kernel oil (PKO), then converts those oils downstream into a wide range of industrial and food ingredients - oleochemicals used in soap, cosmetics, and pharmaceuticals, and specialty fats used in chocolate, infant formula, and baked goods. The finished products are exported to customers in more than 70 countries.

That description is accurate but understates how unusual the business actually is. Most plantation companies stop at the farm gate. Most oleochemical producers are pure manufacturers that buy feedstock from commodity markets. IOI does both, and the integration between the two is the core of what the company has built over five decades.

The founding story matters here. IOI was incorporated in October 1969 as Industrial Oxygen Incorporated - an industrial gases company. The name "IOI" is a relic of that original business. Lee Shin Cheng, who transformed the company into what it is today, pivoted it into oil palm plantations in 1983, followed by property development in 1984, and refineries in 1997. He extended the business into Indonesia in 2007 and built IOI into the most capital-efficient plantation operator in Malaysia - achieving oil yields of approximately six tonnes of crude palm oil per hectare per year against a Malaysian industry average of four tonnes. Lee Shin Cheng died in June 2019. His son, Dato' Lee Yeow Chor, took over as Group Managing Director and Chief Executive and has since steered the group toward higher-value downstream manufacturing while maintaining the plantation efficiency his father built.

In 2013-2014, IOI demerged its property development arm into a separately listed entity, IOI Properties Group Berhad. What remains in IOI Corporation is a pure-play palm value chain from seed to specialty ingredient.

The core value proposition is integration. When CPO prices are high, the plantation segment generates significant profit and the downstream refining margins compress because the input cost for the manufacturing operations rises. When CPO prices fall, the plantation hurts but downstream margins often recover as feedstock becomes cheaper. This natural hedge is imperfect but structural, and it means IOI is less volatile than a pure upstream company. More importantly, the downstream operations - particularly oleochemicals in Europe and specialty fats via its associate Bunge Loders Croklaan - earn margins that are largely decoupled from the commodity CPO price because the value is in the technical transformation, not the raw material.

A concrete example: A pharmaceutical company in Germany needs medium-chain triglycerides (MCTs) for a drug formulation. MCTs are derived from palm kernel oil via a multi-step chemical process involving hydrolysis, fractionation, and esterification. IOI Oleo GmbH in Witten, Germany - a wholly owned subsidiary - is the leading MCT supplier in Europe. That customer cannot easily switch suppliers. The process chemistry took years to develop, the product requires regulatory qualification, and the customer's formulation is built around IOI's specific MCT characteristics. IOI's plantation in Sabah grew the oil palm that produced the palm kernel. IOI's refinery in Pasir Gudang processed it. IOI Oleo in Germany converted it to MCT and sold it. The margin at each step belongs to IOI.


2. Business Segments

2.1 Plantation

IOI's plantation segment is the foundation of the entire business. Oil palm estates across East Malaysia (principally Sabah), Peninsular Malaysia, and Kalimantan in Indonesia supply the raw material - fresh fruit bunches (FFB) - that feeds both IOI's own downstream manufacturing and external customers who buy CPO and PKO at market prices.

What it does: The segment covers the full upstream cycle - seed breeding at IOI's biotechnology center and four research and development centers, cultivation of oil palms across 176,202 hectares of planted land (subsidiary operations), harvest of FFB from 98 estates, and milling at 15 palm oil mills where FFB is pressed to extract CPO and PKO. IOI also holds a 32% stake in Bumitama Agri Ltd, a Singapore-listed Indonesian plantation company with roughly 133,000 hectares of nucleus planted area in Central and West Kalimantan. The effective economic interest through that stake is approximately 43,000 additional hectares.

Geographic breakdown of planted area: East Malaysia (Sabah predominantly) accounts for 64% of IOI's plantation area, Peninsular Malaysia for 24%, and Kalimantan for 12%. The concentration in Sabah is both an advantage and a complication: Sabah's estates are highly productive but require an accelerated replanting program because a large proportion of trees have aged beyond their peak production years. IOI replants approximately 6% of its Malaysian planted area per year.

The core capability: IOI's yield per hectare is the differentiating factor in this segment. Six tonnes of CPO per hectare per year compares to the Malaysian national average of four tonnes over the past two decades. This premium comes from decades of proprietary seed breeding - IOI's biotechnology center has developed high-yielding, disease-resistant oil palm planting materials - combined with intensive agronomic management across the estates. The consequence is that IOI's unit cost of producing a tonne of CPO is structurally lower than most competitors, providing a buffer when commodity prices fall.

Why it is a separate business: The plantation segment has different capital requirements (land, biological assets, long 25-30 year asset life cycles), different regulatory exposure (land titles, environmental approvals, labor law), and fundamentally different drivers than manufacturing. Maintaining it as a distinct P&L gives management and investors clean visibility into upstream profitability versus manufacturing conversion.

Competitive position: Within the plantation world, IOI is a mid-sized player by area relative to Sime Darby Plantation (approximately 578,000 hectares at last count), but it is widely regarded as the most yield-efficient among the large-cap Malaysian planters. The plantation segment generates approximately 60% of group profits in a normal commodity year, though this fluctuates meaningfully with CPO prices.

Strategic priority: The plantation is the cash engine. It provides both the profit flow that funds downstream investment and the feedstock that gives the downstream operations a captive, cost-competitive supply.

2.2 Resource-Based Manufacturing

The RBM segment converts CPO and PKO into progressively higher-value products. It has four distinct sub-businesses at materially different stages of development and maturity: refining, oleochemical, specialty oils and fats (via associate), and two emerging businesses in palm wood and pulp.

2.2a Refinery and Commodity Marketing

IOI operates two refineries in Malaysia with a combined nameplate capacity of 1.80 million MT per year. Crude palm oil and palm kernel oil are refined into processed palm oil products - RBD (refined, bleached, deodorized) palm oil, palm olein, palm stearin, and palm kernel products - which are sold to food manufacturers, industrial buyers, and commodity traders.

The refinery is the most commoditized part of IOI's business. Refining margins are thin, and they are structurally challenged by Indonesian competition. Indonesian refiners source CPO domestically at a lower effective cost because Indonesia's export duty structure creates a price discount for domestic processors that Malaysian refiners cannot match. When IOI refines palm oil in Malaysia, it pays the world price for CPO. When an Indonesian refiner does the same, it sources domestically at a price already reduced by Indonesia's export levy and biodiesel subsidy mechanics. That structural gap has been a persistent drag on Malaysian refinery profitability and has been openly acknowledged by IOI management across multiple quarterly briefings.

Malaysia's periodic adjustments to CPO export duties (the duty on unrefined CPO was raised to 10% for the highest tier in late 2024) have helped Malaysian refiners compete more evenly when CPO prices are elevated, but the underlying structural disadvantage remains.

IOI has responded by focusing the refineries on low-contaminant, food-grade specialty products rather than commodity-grade palm olein, where the Indonesian competition is most direct. This shifts the refinery value proposition from volume throughput to quality premium.

2.2b Oleochemical

This is the most technically sophisticated and defensible part of IOI's downstream business. IOI is the largest vegetable oil-based oleochemical producer in Asia, operating under two wholly owned subsidiaries: IOI Oleochemical Industries Berhad and Pan Century Oleochemical Sdn Bhd, with a combined production capacity exceeding 890,000 MT per year.

Manufacturing facilities are in Prai (Penang, Malaysia), Pasir Gudang (Johor, Malaysia), and through IOI Oleo GmbH in Witten and Wittenberge (Germany). The German operations are headquartered in Hamburg and employ more than 330 people. Products from these facilities reach customers in more than 80 countries, with distribution centers in Europe, Japan, and the United States.

The product range covers fatty acids (sold under the Palmac® brand), glycerine, soap noodles (Palmsabun®), fatty esters (Palmsurf®), fatty alcohols, metallic stearates, and a range of specialty downstream derivatives including medium-chain triglycerides (MCTs). IOI Oleo GmbH is specifically the leading MCT supplier in Europe.

The technical depth here is genuine. IOI installed the world's first continuous reactive distillation fatty ester plants in 2004 and 2008. The company operates multi-step short-path distillation, fractionation, esterification, and reactive distillation processes. These are not simple mixing operations - they require significant process chemistry expertise, specialized equipment, and years of product qualification with customers. The German operations in particular serve the pharmaceutical and cosmetics industries where product consistency, regulatory documentation, and supplier reliability matter far more than price alone. Products carry RSPO, Halal, Kosher for Passover, and API certifications.

The oleochemical segment faces two recurring challenges. First, palm kernel oil is the primary feedstock for the higher-value derivatives (fatty alcohols, MCTs, lauric fatty acids), and when PKO prices spike - as they did for extended periods in FY2024 and early FY2025 - margins compress and sales volumes fall as customers reformulate or defer purchases. Second, Indonesian oleochemical producers, backed by Indonesia's upstream cost advantage, compete aggressively in the commodity-tier fatty acids and soaps. IOI's defense is product mix migration toward high-value specialties and the German customer base, which is less price-sensitive than Asian commodity buyers.

2.2c Specialty Oils and Fats

This business is operated by Bunge Loders Croklaan (formerly IOI Loders Croklaan), in which IOI holds approximately 20-30% of the equity. Bunge Limited acquired a 70% ownership interest from IOI in 2018. IOI retains its minority stake and accounts for its share of earnings as an associate contribution - meaning it appears below the operating line in IOI's accounts, but it is strategically central to IOI's identity as a value-added palm ingredients business.

Bunge Loders Croklaan is among the world's leading producers of specialty fats for the confectionery and food ingredient industries. Its product focus is fractionated palm mid-fraction and other tropical fats used to create cocoa butter equivalents (CBE), cocoa butter substitutes (CBS), and cocoa butter replacers (CBR) for chocolate and confectionery manufacturers who cannot or do not want to use pure cocoa butter.

This business has unusual competitive dynamics. Cocoa butter prices have surged dramatically following successive cocoa harvest failures in West Africa, and the attractiveness of high-quality CBE - which substitutes for cocoa butter in premium chocolate applications - has increased accordingly. Bunge Loders' CBE products command strong margins when cocoa butter is expensive, and the Karibon patent-pending shea-based CBE product represents a further move up the quality spectrum.

Manufacturing sites include the Netherlands (a new state-of-the-art plant in Amsterdam's HoogTij industrial area, Phase 1 expected completion September 2026, replacing the older Wormerveer facility), North America (a plant in New Orleans, with a second plant adding 5-10% capacity, expected completion in early 2026), Malaysia, Canada, Ghana, and China. The Amsterdam plant alone required investment of over €300 million and achieves 40% direct energy savings versus the previous facility.

IOI's strategic relationship with Bunge Loders is both a strength and a constraint. IOI does not control the business - Bunge does. IOI benefits from associate earnings and the relationship deepens the integration narrative, but capital allocation decisions in Bunge Loders are not IOI's to make.

2.2d Palm Wood (IOI Palm Wood)

Established in 2020, IOI Palm Wood is Malaysia's first commercial manufacturing operation converting oil palm trunks - previously discarded agricultural waste during replanting - into engineered wood panels. The product, branded OnCore®, includes thermally modified palm lumber, blockboards, and engineered palm wood panels for furniture and construction applications.

The technical challenge is significant. Oil palm trunks contain moisture at 150-600% of dry mass, plus sugars and starches that cause rapid fungal decay if not processed quickly. The manufacturing process requires specialized rapid-logistics systems to move trunks from field to factory before degradation begins, followed by complex thermal modification and drying protocols. IOI spent years developing adapted machinery and process knowledge.

The strategic logic is elegant: IOI's replanting program across its Malaysian estates generates an enormous and regular supply of oil palm trunks. Converting this waste stream into a commercial product generates revenue from material that previously had no value and needed to be disposed of. It also positions IOI against deforestation criticism by demonstrating that plantation replanting generates sustainable timber alternatives.

This business is at an early commercial stage. Revenue contribution is nascent.

2.2e Pulp and Paper (Nextgreen IOI Pulp)

IOI holds a 45% stake in Nextgreen IOI Pulp Sdn Bhd, a joint venture with Nextgreen Global Berhad (55%) and backed by Xiamen C&D Paper & Pulp Group from China. The venture is building Malaysia's first large-scale zero-waste pulp facility at the Green Technology Park in Pekan, Pahang.

The feedstock is empty fruit bunches (EFB) - the fibrous residue remaining after FFB is pressed in the palm oil mill. EFB is produced in enormous quantities by IOI's mills and has historically been used as compost or for energy. Converting it to wood-free pulp for paper, tissue, and packaging applications creates a substantially higher-value product from a waste stream.

Phase 1 capacity is 150,000 MT of pulp per year, with a total capital expenditure of RM900 million across the full project. Commissioning is expected in FY2027-2028.

This venture is not contributing to earnings yet, but it is significant because it closes the loop on IOI's plantation waste streams: oil palm trunks (replanting waste) become IOI Palm Wood panels, and EFB (milling waste) becomes pulp. Both represent the kind of higher-value use of by-products that the 2025-2029 strategic roadmap is organized around.

Segment Summary Table

SegmentWhat It DoesKey End MarketsCompetitive EdgeStrategic Priority
PlantationGrows oil palm, extracts CPO/PKOCommodity buyers, internal downstreamHighest yield/ha in industry (~6t/ha/yr)Cash engine, feedstock supplier
RefineryRefines CPO/PKO to processed palm productsFood manufacturers, commodity tradersLow-contaminant specialty gradesChallenged - structural Indonesian competition
OleochemicalConverts PKO/CPO to fatty chemicalsPharma, cosmetics, food, home careGermany operations (MCT leadership), process depthCore manufacturing value-add
Specialty FatsCBE/CBS/CBR for confectionery (via associate)Chocolate, bakery, infant nutritionPremium products, expanding capacityAssociate earnings growth driver
Palm WoodOil palm trunk to engineered wood panelsFurniture, constructionOnly commercial-scale operator in MalaysiaEarly-stage, long-term bet
PulpEFB to wood-free pulp (JV, not yet operating)Paper, packagingWaste-to-product, first-mover in MalaysiaLong-term, FY27-28 commissioning

3. Products and Business Detail

Palm Oil Milling and Refinery Chain

The plantation-to-refinery chain begins with harvesting FFB - the heavy bunches of palm fruit that must be processed within 24 hours of cutting to prevent free fatty acid development in the oil. IOI's 15 palm oil mills are positioned to receive FFB from nearby estates, maintaining this freshness requirement. Inside the mill, FFB is sterilized under steam, threshed to separate individual fruit from the bunch, digested and pressed to extract crude palm oil, and centrifuged to clarify it. The press cake - palm kernel - is cracked to yield palm kernel shells and kernels, which are further processed to yield palm kernel oil (PKO) and palm kernel expeller (PKE, an animal feed ingredient).

The CPO and PKO then move to IOI's two refineries, which convert them through a degumming, bleaching, and deodorization (RBD) process into food-grade palm oil products. The refineries also fractionate palm oil into palm olein (the liquid fraction, used in cooking oil and food manufacturing) and palm stearin (the solid fraction, used in margarines, shortenings, and as a feedstock for oleochemical production). Combined nameplate capacity of 1.80 million MT per year positions IOI's refinery system as a major Malaysian processor.

Oleochemical Product Catalogue

Fatty Acids (Palmac® range): The most fundamental oleochemical building block. Palm or palm kernel oil is hydrolyzed (split) to yield fatty acids and glycerine. Different chain lengths serve different markets: C12 (lauric acid) for soaps and personal care; C16 (palmitic acid) for food-grade applications; C18 (stearic acid) for rubber, plastics, and cosmetics; short-chain fatty acids for fragrances and flavors. IOI offers distilled and fractionated variants for specific application requirements.

Glycerine: A co-product of fatty acid production, glycerine is used in pharmaceuticals, cosmetics, food processing, and industrial applications. IOI produces both crude and refined glycerine grades.

Soap Noodles (Palmsabun®): Semi-finished soap base sold to soap manufacturers who stamp, cut, and brand it. IOI's patent-pending "saturated soap" noodle is marketed as a natural, preservative-free, chelating-free product - targeting the green personal care trend.

Fatty Esters (Palmsurf® range): Produced by esterifying fatty acids with various alcohols. Applications span cosmetics (emollients), lubricants (synthetic and bio-lubricants), and food (food-grade emulsifiers). IOI's installation of the world's first continuous reactive distillation fatty ester plants in 2004 and 2008 was a genuine technical innovation that allows production of fatty esters at higher efficiency and purity than batch processes.

Medium-Chain Triglycerides (MCTs): Produced from coconut or palm kernel lauric fractions via hydrolysis and re-esterification with glycerol. IOI Oleo GmbH is the leading MCT supplier in Europe. MCTs are used in pharmaceutical drug delivery (as an excipient), nutritional supplements (marketed as "MCT oil" for ketogenic diets), cosmetics (skin feel), and specialty food. This is among IOI's highest-value oleochemical products, and the German facility's dominance in European MCT supply reflects years of customer qualification and process refinement.

Fatty Alcohols: Produced by hydrogenating fatty acids under pressure. Used in cosmetics, personal care (as emulsifiers and thickeners), and industrial applications. IOI competes here against dedicated fatty alcohol producers such as KLK's Emery Oleochemicals and BASF.

Metallic Stearates: Fatty acids reacted with metal salts (calcium, zinc, magnesium). Used as lubricants in PVC processing, release agents in rubber and plastics, and as stabilizers in polymer formulations. A specialty industrial chemical segment within the broader fatty acid family.

Specialty Fats Products (via Bunge Loders Croklaan)

The specialty fats business revolves around fractionating palm mid-fraction (PMF) - a specific solid fraction of palm oil obtained by careful controlled crystallization - to create products that mimic cocoa butter's melting profile and functionality.

Cocoa Butter Equivalents (CBE): True equivalents that can be blended with cocoa butter at up to 5% in European chocolate formulations (under EU Chocolate Directive) without losing the "chocolate" label. Require palm mid-fraction meeting strict symmetrical triglyceride specifications, often blended with shea, illipe, or sal fats. These are technically the most demanding product in the range and command the highest margin. Bunge Loders' Karibon - a 100% shea-based CBE - represents a premium alternative aimed at customers concerned about the palm sustainability story.

Cocoa Butter Substitutes (CBS): Lauric fats (from palm kernel or coconut oil) that substitute cocoa butter in compound chocolate and coating applications where the chocolate label is not required. Faster setting time, strong flavor release, but incompatible with cocoa butter in the same formulation.

Cocoa Butter Replacers (CBR): Partially hydrogenated or fractionated vegetable oils that provide CBE-like performance without the specific triglyceride requirements. Used in bakery fillings, ice cream coatings, and biscuit creams.

Bakery Fats, Margarines, Shortenings, Infant Nutrition Fats: Bunge Loders supplies the broader food industry with functional fats for these applications, using its fractionation and blending expertise to create products with specific melting points, textures, and nutritional profiles.

The new Amsterdam facility - replacing the Wormerveer and Rotterdam locations - is designed with state-of-the-art CBE production capabilities, delivering 40% direct energy savings and targeting a 90% CO2 reduction by 2030. Phase 1 commissioning is expected by September 2026.

Geographies

IOI's plantation operations are anchored in Sabah (East Malaysia), which accounts for roughly 64% of planted area. Sabah's climate and soils are well-suited to oil palm, but the concentration creates exposure to localized weather events, disease outbreaks, and labor availability challenges. Peninsular Malaysia (24%) adds geographic diversification and logistical flexibility. The Kalimantan estates (12% of IOI's own area, plus the Bumitama associate in Central and West Kalimantan) provide exposure to Indonesian growth without full operational control.

The oleochemical manufacturing footprint spans Malaysia (Prai and Pasir Gudang) and Germany (Witten and Wittenberge). The German operations are specifically positioned to serve European pharmaceutical and cosmetics customers who value supply chain proximity and EU regulatory compliance. Products from IOI's Malaysian oleochemical plants serve Asian, Middle Eastern, and US markets.

Specialty fats manufacturing under Bunge Loders covers the Netherlands (the new Amsterdam plant), North America (New Orleans), Malaysia, Canada, Ghana, and China - designed to provide each major confectionery manufacturing region with proximate supply of time-sensitive fractionated products.


4. Customers

Plantation Segment Customers

CPO and PKO from IOI's mills and refineries are sold to two broad categories: commodity traders who redistribute into global vegetable oil markets, and directly to food manufacturers in Asia, Europe, and the Middle East. The commodity trading portion is essentially price-taking, with sales contracts largely spot or short-term forward. The refinery sells processed palm products into similar channels.

The switching cost for commodity customers is essentially zero - palm oil is a fungible global commodity and buyers switch between suppliers based on price and certification status. What protects IOI at the margin is RSPO certification: large multinational consumer goods companies (Unilever, Nestlé, Colgate-Palmolive, P&G) have committed to sourcing only RSPO-certified palm oil and will only contract with certified suppliers. IOI's loss of RSPO certification for five months in 2016 demonstrated this dependency vividly - more than 27 multinational companies cancelled contracts immediately, with 50%+ of revenues estimated to flow through RSPO-certified sales channels.

Oleochemical Customers

Oleochemical customers are structured very differently. The pharmaceutical and cosmetics industry buyers in Europe, Japan, and North America operate under stringent quality management systems. Before qualifying a new oleochemical supplier, they run extensive analytical testing, documentation review, and often audit the manufacturing facility. A pharmaceutical company using IOI Oleo GmbH's MCTs as a drug excipient has embedded that supplier into its regulatory dossier - changing the supplier means re-filing the regulatory documentation, which is expensive and time-consuming. This creates sticky long-term relationships.

IOI Oleo GmbH's statement that customers "include some of the world's largest multinational corporations" is consistent with what European pharmaceutical and cosmetics supply chains look like: companies like BASF, Evonik, and specialty chemical distributors purchasing bulk fatty chemicals, alongside direct procurement by major consumer brands.

For soap noodles and commodity fatty acids, the customer base is more price-sensitive - soap manufacturers in South and Southeast Asia, Middle Eastern markets, and Africa buy in volume and will switch on price. IOI competes here on reliability, certification, and the logistical advantage of Malaysian production for Asian buyers.

Specialty Fats Customers (Bunge Loders Croklaan)

The confectionery and bakery ingredient buyers are multinational chocolate and biscuit manufacturers - names like Mars, Barry Callebaut, Mondelez, Ferrero, and the major private label chocolate compounders. These buyers have technical development teams that work directly with ingredient suppliers to reformulate products around specific fat specifications. A CBE formulation is developed with a specific supplier's PMF characteristics in mind. Switching suppliers requires reformulation, sensory testing, stability studies, and potentially regulatory re-assessment in some markets. This creates meaningful switching costs.

The infant nutrition segment is even stickier - specialty fats used in infant formula are subject to strict regulatory qualification, and manufacturers do not change suppliers without compelling reason.

Contract structures in specialty fats tend to be annual or multi-year supply agreements with volume commitments, moving toward relationship-based accounts with technical collaboration rather than spot purchasing.


5. Competitive Landscape

Plantation Tier

The Malaysian and Indonesian plantation sector is dominated by a small number of large-cap groups: Sime Darby Plantation (Malaysia's largest by planted area, ~578,000 hectares), Kuala Lumpur Kepong (KLK, a Malaysia-listed diversified plantation and manufacturing group), Wilmar International (Singapore-listed, primarily a processing and distribution giant), Golden Agri-Resources (Indonesia/Singapore), and United Plantations (smaller, best-in-class yield in Peninsular Malaysia).

IOI's competitive position in this tier is defined by yield efficiency. Its approximately 6 tonnes CPO per hectare per year output compares favorably to the industry average of 4 tonnes and is the main reason plantation returns are structurally better than most peers on a per-hectare basis. KLK and United Plantations have reputations for similarly disciplined agronomy, but IOI's combination of scale (176,000+ hectares subsidiary, plus Bumitama associate) and yield premium is difficult to replicate. Sime Darby is larger by hectares but has historically traded at lower yield efficiency given its broader geographic spread and more complex organizational history.

The key barrier to entry in plantation is time - oil palms take 3-4 years from planting to first commercial yield, reach peak productivity at 7-14 years, and remain productive for 25 years. Land acquisition in Malaysia and Indonesia has become increasingly constrained by government restrictions and sustainability commitments, making greenfield expansion expensive and slow. New entrants cannot match IOI's 40 years of estate management and proprietary seed genetics.

Refinery Tier

This is where IOI is most competitively exposed. Indonesian refiners - including Wilmar's Indonesian operations, Asian Agri (Raja Garuda Mas Group), and Musim Mas - have a structural feedstock cost advantage because Indonesia's export levy on unrefined CPO effectively subsidizes domestic processing. When CPO prices rise, this advantage widens because the duty differential is larger in absolute terms.

IOI's Malaysian refineries compete by targeting low-contaminant and specialty-grade refined products where quality specifications reduce the Indonesian commodity competition. But the business remains margin-thin and management has consistently flagged it as a challenge.

Oleochemical Tier

The key oleochemical competitors globally are KLK (via its downstream subsidiary Emery Oleochemicals, a joint venture with Germany's BASF in specialty esters and polyols), Wilmar (primarily Asian commodity oleochemicals), and in Europe, the major chemical companies BASF, Evonik, Sasol, and Croda who produce synthetic and oleochemical-derived specialties. IOI is the largest Asian vegetable oil-based oleochemical producer by capacity (890,000+ MT per year), but the German operations, specifically the MCT leadership position and specialty ester capabilities, are what generate the premium margins and sticky customer relationships.

IOI's differentiation against BASF or Evonik is the natural/sustainable raw material story - European pharmaceutical and cosmetics buyers increasingly want traceable, sustainably certified vegetable-based inputs rather than petroleum-derived alternatives. IOI's RSPO traceability (97.87% traceable to plantation level) and ISCC certification are genuine differentiators in this context.

The oleochemical segment does not have a simple moat. Capacity is available globally, and commodity-tier fatty acids are price-competitive. The moat exists specifically in the specialty derivatives - MCTs, pharmaceutical-grade fatty esters, metallic stearates - where product qualification and process expertise create stickiness.

Specialty Fats Tier

Bunge Loders Croklaan competes primarily against Cargill (which produces shea-based specialty fats and CBE products through its cocoa processing operations), AAK (Swedish, one of the world's largest specialty fats producers with strong CBE capability), and Fuji Oil (Japanese, significant CBE presence in Asia). IOI's influence in this tier is via its minority stake in Bunge Loders, giving it economics without operational control.

The specialty fats market is a two-horse race between Bunge Loders and AAK for European CBE leadership, with Cargill competing strongly in North America and Asia. High barriers to entry: CBE production requires controlling palm mid-fraction quality to sub-degree triglyceride specifications, which demands sophisticated analytical chemistry, crystallization expertise, and years of customer qualification. A new entrant would take 5-7 years to develop the process expertise and achieve customer qualification at scale.


6. Industry

Demand Drivers

Palm oil is the world's most produced and consumed edible oil, accounting for approximately 40% of global edible oil trade. Demand grows with population growth (particularly in Asia and Africa), rising incomes that shift consumption toward packaged food and personal care products, and the increasing use of palm derivatives in oleochemicals as the cosmetics, pharmaceutical, and home care industries seek plant-based alternatives to petroleum-derived raw materials.

Indonesia's B40 biodiesel mandate - requiring diesel fuel to be blended with 40% palm oil - which came into effect in 2025, has materially increased domestic Indonesian demand for CPO. The program absorbed an additional 2.62 million kiloliters of biodiesel production versus the prior B35 standard. Indonesia is actively considering a further step to B50, which would absorb approximately 3 million tonnes of additional CPO per year. This has two implications for IOI: it reduces Indonesian CPO export availability, supporting global CPO price levels; and it modestly reduces the feedstock cost advantage of Indonesian refiners (as more domestic CPO is absorbed by the biofuel mandate, less is available cheaply for industrial use).

Industry Size and Global Supply Chain

The global palm oil market was valued at approximately USD 66-75 billion in 2024-2025, with most forecasts projecting growth at roughly 4-5% CAGR through 2032-2035. Indonesia and Malaysia together produce more than 80% of global palm oil supply. Indonesia leads with approximately 59% global market share in production; Malaysia's production is forecast at roughly 19.5 million MT in FY2025-26.

IOI sits in the middle of this supply chain. Its plantations are small relative to the Indonesian giants by area but more efficient per hectare. Its downstream operations add genuine chemical transformation value. The end products - pharmaceutical MCTs, CBE for confectionery, certified sustainable palm oil - are consumed by global multinationals as ingredients in final consumer products.

Regulatory Environment

The EU Deforestation Regulation (EUDR), which came into force with a deforestation cut-off date of December 31, 2020, requires that palm oil and its derivatives entering the EU market can be proven free from deforestation. IOI has implemented EUDR compliance processes across its mills and plantations and is communicating traceability requirements to its third-party supplier mills. At 97.87% traceability to plantation level for CPO sourced from supplying mills, IOI is relatively advanced in this compliance journey. However, the regulation represents ongoing compliance costs and potential market access risk if the traceability systems fail or if any part of the supply chain (particularly third-party supplier mills) cannot be verified.

Malaysia's own MSPO 2.0 certification scheme mandates no conversion of natural forests after December 2019, preceding the EUDR cut-off. IOI is 100% MSPO-certified across its 84 Malaysian estates and 14 mills. This domestic certification is increasingly aligned with EUDR requirements.

RSPO certification remains commercially critical because major European and North American consumer goods companies have committed to certified palm oil. IOI's 2016 RSPO suspension - triggered by deforestation allegations in Kalimantan - resulted in the immediate cancellation of contracts by more than 27 multinationals. The RSPO restored certification in August 2016 after remediation measures, but the episode demonstrated that non-compliance is not merely reputational - it is directly revenue-destructive.

Cyclicality

Palm oil is a commodity business at its core and is therefore cyclical. CPO prices have ranged from below RM2,000/MT in difficult years to above RM7,000/MT during the 2022 supply shock driven by the Ukraine conflict and Indonesian export restrictions. The current price environment is more normalized at around RM4,000-4,500/MT.

Oleochemical margins are driven by the spread between palm kernel oil prices (feedstock) and finished product prices. When PKO prices spike relative to finished goods prices, margins compress and customers defer purchases. The recovery of oleochemical margins in IOI's Q1 FY2026 followed a decline in PKO prices from elevated levels - illustrating the cyclical feedstock dynamic.

Specialty fats margins via Bunge Loders are somewhat counter-cyclical to cocoa markets - when cocoa butter prices rise (as they have dramatically since 2023 due to West African crop failures), demand for CBE substitutes strengthens and CBE margins improve.


7. Growth Triggers

The following triggers are sourced directly from IOI's quarterly results presentations and management statements across the four most recent quarters. All are forward-looking as of the date stated.

  • Higher FFB production growth in FY2026, projected at 5-8% year-on-year, driven by a larger proportion of palms reaching prime producing age (7-14 years) and young palms planted during the 2020-2023 period coming into maturity, despite the ongoing accelerated replanting program in Sabah absorbing some productive trees. (Q1 FY2026 Results Presentation, November 2025)

"Fresh fruit bunch production is projected to be higher, driven by a larger proportion of palms reaching prime age and young palms coming into maturity, despite ongoing accelerated replanting in Sabah." - IOI Q1 FY2026 Results Summary

  • CPO price expected to remain above RM4,000/MT over the next three to four months from November 2025, supported by tighter global supply from Indonesia's B40 biofuel mandate absorbing domestic CPO and production seasonality. (Q1 FY2026 Results Presentation, November 2025)

  • Oleochemical segment recovery following turnaround in Q1 FY2026, driven by sharply lower palm kernel oil prices releasing margin pressure that had been suppressing both volumes and margins for extended periods. IOI's limited exposure to the Indonesian oleochemical market (where prices have softened) was explicitly noted as a resilience factor. (Q2 FY2026 Results, February 2026; confirmed the recovery initiated in Q1 FY2026)

  • Bunge Loders Croklaan's second plant in New Orleans expected to complete within the next six months from February 2026, lifting Bunge Loders' production capacity for cocoa butter equivalents and cocoa butter replacers by 5-10% year-on-year. IOI benefits via its associate equity earnings. (Q2 FY2026 Results, February 2026)

"Completion of the expansion of the New Orleans plant in the next six months will strengthen its American operations." - IOI Q2 FY2026 Results Summary

  • Bunge Loders Croklaan Amsterdam plant Phase 1 commissioning targeted by September 2026, replacing the older Wormerveer facility with a state-of-the-art CBE production plant delivering 40% direct energy savings. The new plant increases production efficiency and positions Bunge Loders for growth in the European premium specialty fats market. (Q3 FY2025 Results Presentation, May 2025; repeated in Q2 FY2026 Results, February 2026)

  • Specialty fats CBE margins expected to remain strong, underpinned by continued high cocoa butter prices that make CBE substitutes attractive to confectionery manufacturers, and incremental capacity from the New Orleans and Amsterdam expansions. Associate pre-tax profit grew 23% quarter-on-quarter in Q2 FY2026. (Q3 FY2025 Presentation; Q2 FY2026 Results)

  • Coconut plantation expansion from 3,000 hectares to 5,000 hectares, with construction of a coconut oil mill complex in Segamat set to commence and targeting commissioning by 2028. The mill will initially process approximately 100,000 coconuts per day, scaling to 200,000. This is part of the 2025-2029 strategic roadmap's diversification into adjacent agricultural commodities. (Referenced in analyst coverage and IOI corporate communications, early 2026)

  • EFB-to-pulp JV (Nextgreen IOI Pulp, 150,000 MT/year Phase 1) targeting commissioning in FY2027-2028, with total capital expenditure of RM900 million across the full project. The joint venture converts palm milling waste into wood-free pulp for paper and packaging, providing a new revenue stream from currently zero-value by-products. (Referenced in Q1 FY2026 analyst briefings and company announcements)

  • New Five-Year Strategic Roadmap 2025-2029 launched in January 2025, explicitly targeting movement higher in the value chain via more innovative products and solutions in oleochemical specialties and sustainable palm ingredients. This sets the strategic direction for capex allocation over the coming five years. (Annual Report FY2025; roadmap launch January 2025)

TriggerTimelineSourceStatus
FFB production +5-8% in FY2026FY2026 full yearQ1 FY2026 (Nov 2025)New guidance
CPO price above RM4,000/MT3-4 months from Nov 2025Q1 FY2026 (Nov 2025)Time-bound guidance
Oleochemical recoveryOngoing from Q1 FY2026Q2 FY2026 (Feb 2026)Confirmed recovery underway
Bunge Loders New Orleans expansionEarly 2026Q2 FY2026 (Feb 2026)New, specific timeline
Bunge Loders Amsterdam Phase 1Sept 2026Q3 FY2025 (May 2025)Repeated across 2 presentations
Specialty fats CBE margins strongOngoingQ3 FY2025 (May 2025), Q2 FY2026 (Feb 2026)Repeated, confirmed
Coconut mill SegamatCommission by 2028Analyst coverage, early 2026New venture
EFB pulp JV commissioningFY2027-2028Q1 FY2026 briefingsMedium-term

8. Key Risks

1. CPO Price Volatility

Mechanism: The plantation segment generates approximately 60% of IOI's profits in a normal year. CPO is a globally traded commodity whose price is driven by supply-demand dynamics across multiple competing oils (soybean oil, sunflower, rapeseed), Indonesian export and biodiesel policy, Malaysian production volumes, and speculative capital flows. A 20-30% decline in CPO prices from current levels would materially reduce plantation profitability and may not be offset by downstream margin improvement if refinery and oleochemical spreads are also compressed.

Calibration: High probability, moderate annual drag. This risk manifests every cycle and is the primary driver of earnings volatility. Management consistently acknowledges it; no unusual protection beyond integration.

2. Structural Disadvantage in Malaysian Refining

Mechanism: Indonesia's CPO export levy and domestic feedstock pricing policy creates a cost advantage for Indonesian refiners of approximately USD 30-50/MT versus Malaysian competitors (the estimate varies by CPO price level). As long as this policy persists, Malaysian-based refinery operations face structural margin compression when competing for the same end customers in Asia. IOI cannot match the Indonesian cost structure by refining in Malaysia, and moving refinery operations to Indonesia is not a near-term option.

Calibration: High probability, persistent moderate drag. Management has flagged this consistently across all four recent quarterly periods. The risk is structural unless Malaysian CPO export duties are adjusted or Indonesian policy changes. IOI's response - shifting refinery mix toward specialty grades - partially mitigates but does not eliminate this disadvantage.

3. Palm Kernel Oil Price Exposure in Oleochemical

Mechanism: Many of IOI's highest-value oleochemical products (MCTs, fatty alcohols, lauric fatty acids, soap noodles) are derived from palm kernel oil rather than CPO. PKO prices are driven by a different supply-demand balance than CPO and can spike independently. When PKO prices rise sharply relative to downstream product prices, oleochemical margins compress and customer demand softens as buyers reduce inventory and reformulate. IOI experienced this dynamic acutely in FY2024 and much of FY2025 before the PKO price decline in mid-2025 began to restore margins.

Calibration: Medium probability, medium to high impact when it occurs. The recent oleochemical recovery is directly dependent on PKO prices remaining at lower levels. A return of elevated PKO prices would reverse the improvement management has guided.

4. EUDR and Sustainability Regulatory Risk

Mechanism: The EU Deforestation Regulation requires all palm oil and derivatives entering EU markets to be certified deforestation-free based on geospatial data traceable to the plot of land where production occurred. IOI's supply chain includes both its own certified estates (where traceability is strong) and third-party supplier mills (where traceability to plantation level is below 90% for palm kernel). If a portion of IOI's supply chain cannot be verified under EUDR, it risks losing EU market access for those volumes. The European market represents a significant portion of the oleochemical and specialty fats business value.

Calibration: Medium probability, potentially high impact if EUDR enforcement is strict. IOI is proactively working on supplier compliance and is tracking better than many peers, but the regulation is new and enforcement complexity remains to be tested.

5. Reputational and ESG Risk (RSPO/Customer Cancellation)

Mechanism: The 2016 RSPO suspension demonstrated that IOI's business model is specifically vulnerable to sustainability certification loss. More than 27 multinationals cancelled supply contracts immediately upon suspension; IOI's net income was negative for the affected quarter. The company estimates that over 50% of its revenues at the time were linked to RSPO-certified supply. A repeat deforestation allegation - particularly involving third-party supplier mills in Indonesia that IOI may have less direct control over - could trigger a similar cascade.

Calibration: Low-to-medium probability given IOI's proactive sustainability investment since 2016, but catastrophic impact if it occurs. IOI has implemented significant monitoring and supplier engagement programs, but the supply chain extends to independent third-party mills it cannot fully control.

6. Currency Risk

Mechanism: IOI's costs are primarily in Malaysian Ringgit, but its revenues are predominantly received in or referenced to USD (for commodities) and EUR (for European oleochemical and specialty fats sales). A strengthening RM against USD compresses plantation realization when CPO prices (which are USD-referenced) are converted back to RM. IOI's Q1 FY2026 management commentary explicitly noted that a stronger Ringgit in November 2025 was one of two factors (alongside higher East Malaysia production) that caused a near-term CPO price dip.

Calibration: High probability (exchange rates move constantly), low-to-moderate impact per unit move, but cumulatively significant over earnings cycles.

7. Replanting-Cycle Production Dip in Sabah

Mechanism: IOI's accelerated replanting program in Sabah - replacing aging trees with superior new planting materials - involves uprooting productive trees before planting new ones. New palms take 3-4 years to produce commercially. During the transition, Sabah's output per hectare declines. IOI is replanting approximately 6% of Malaysian planted area per year. This is deliberate and strategically sound (new materials will achieve higher yields at maturity) but creates a near-to-medium-term production headwind from its largest producing region.

Calibration: Certain to occur and is occurring. Management has flagged it in multiple quarters. The impact is partially offset by other estates' production improving as young palms mature.


9. Walk the Talk

IOI does not conduct traditional Western-style investor conference calls with live Q&A. Instead, it releases quarterly results summary presentations and accompanying financial statements. The four most recent periods - Q3 FY2025 (approximately May 2025), Q4 FY2025/Full Year (August 2025), Q1 FY2026 (November 2025), and Q2 FY2026 (February 2026) - constitute the management guidance record that can be evaluated.

Q3 FY2025 (approximately May 2025): Management projected CPO prices to range between RM3,700 and RM4,000 per MT for the remainder of FY2025 (i.e., through June 2025). It stated that FFB production in Q4 FY2025 was expected to "recover significantly" from Q3 FY2025. On the downstream side, management characterized the oleochemical environment as "challenging" - specifically noting that high PKO prices were subduing volumes and margins - and said this was expected to persist. For specialty fats via Bunge Loders, it guided that CBE margins were "expected to remain good" through Q4 FY2025, with North American plants not expected to be affected by US tariffs. It also flagged MYR/USD volatility as a persistent risk from US trade policy uncertainty.

These statements were broadly accurate. CPO in Q4 FY2025 did recover toward the upper end of the guided range. Q4 FFB production did recover as guided. The oleochemical segment remained pressured through FY2025. Specialty fats CBE margins were indeed good, contributing to the full-year earnings beat. The guidance was directionally correct across all points - notably, management did not overpromise a downstream recovery it could not deliver.

Q4 FY2025 / Full Year Results (August 2025): IOI's full year FY2025 results beat analyst expectations, with the plantation segment benefiting from CPO prices rising to an average of approximately RM4,332 per tonne across the year. Management launched the new Five-Year Strategic Roadmap 2025-2029 and stated that FFB production in FY2026 would be "higher than FY2025" driven by maturing trees. CPO prices at the time of announcement had risen to approximately RM4,500 per tonne, and management stated it expected prices to "remain strong."

The early evidence from Q1 FY2026 results (released November 2025) confirmed this: plantation underlying profit was indeed 14% higher than Q1 FY2025 as both CPO price and FFB production rose year-on-year. The guidance on CPO strength was proven premature in detail (CPO corrected below RM4,200 in November 2025 on East Malaysia overproduction), but the full-quarter averages supported the directional view.

Q1 FY2026 (November 2025): Management delivered the most specific CPO price guidance of recent periods - expecting prices to "remain above RM4,000/MT over the next three to four months." It confirmed that the oleochemical segment had turned around in Q1 FY2026, with a 249% year-on-year improvement in underlying profit driven by both the refinery sub-segment benefiting from the Malaysian CPO duty increase and the oleochemical sub-segment's margin recovery from lower PKO prices. Management also stated that FFB production growth of 5-8% for full-year FY2026 was expected.

The subsequent Q2 FY2026 results (December quarter) confirmed continued strong plantation performance and CBE margins at Bunge Loders, with the associate's pre-tax profit up 23% quarter-on-quarter. However, the oleochemical sub-segment profit slipped 49% quarter-on-quarter in Q2 FY2026 versus Q1 FY2026 as margin improvement faded. This means the "turnaround" language from Q1 was partially accurate (the segment did recover year-on-year) but overstated the sustainability of the Q1 jump on a sequential basis. Management was not wrong, but the oleochemical recovery proved to be a one-quarter spike rather than a sustained inflection.

Q2 FY2026 (February 2026): Management guided that overall operating and financial performance for "the remaining quarters of FY2026" would be "resilient." It maintained that the plantation segment would deliver resilient performance for the full year. It acknowledged that downstream refining and oleochemical conditions "remain challenging" - a consistent refrain that has now been repeated across five consecutive quarters. For specialty fats, management expressed confidence in continued strong CBE margins and noted the imminent completion of the New Orleans plant expansion.

Overall Assessment: IOI's management is consistently honest about downstream challenges. The "tough downstream" refrain is not spin - the structural refinery pressure and oleochemical cyclicality are real, and management has never tried to obscure them. On the plantation side, guidance has been directionally accurate, with management correctly calling the CPO price trajectory and FFB production recovery in most periods. The one recurring gap is oleochemical - management guides for "expected improvement" but the timing and magnitude of recovery has been difficult to pin down precisely. The oleochemical segment has disappointed relative to guidance in several consecutive quarters before finally recovering in Q1 FY2026. There is also a tendency to use qualitative language ("resilient," "expect to remain good") that is directionally useful but difficult to hold management precisely accountable to. This is common in Malaysian public companies but does limit the quality of the guidance track record versus Western counterparts who provide numerical ranges.

The Five-Year Strategic Roadmap launched in January 2025 carries the most significant promise - becoming a "global leader in sustainable palm products and ingredients" by moving higher in the value chain. This is a multi-year commitment that cannot yet be evaluated against outcomes.


10. Scenarios

Bull Case

CPO prices remain anchored above RM4,000 per tonne through 2026-2027, supported by Indonesia's deepening biofuel mandate (B50 implementation absorbing additional Indonesian domestic supply) and continued growth in Asian food and biodiesel demand. IOI's plantation segment, with its FFB production recovery driven by maturing palms, generates strong upstream cash flows. The replanting cycle in Sabah approaches its inflection point as new high-yielding palms enter productive age, setting the stage for a yield-per-hectare re-rating in the late 2020s.

Downstream, the Bunge Loders Amsterdam plant commissions on schedule in September 2026 and, combined with the New Orleans expansion, helps lift the associate's earnings contribution to IOI meaningfully. Cocoa butter equivalent margins remain elevated as cocoa butter prices stay high, and the confectionery industry accelerates its shift to CBE-based formulations as a cost and sustainability measure. Bunge Loders' geographic expansion into North America delivers incremental market share.

IOI Oleo GmbH's MCT business benefits from the surge in consumer demand for MCT oil as a functional food ingredient, and the oleochemical segment as a whole earns structurally better margins as PKO prices normalize at lower levels, enabling the European customer base to re-engage with specialty derivatives purchasing. IOI's move into coconut oil (the Segamat mill) and EFB pulp provides early tangible evidence that the value-chain migration strategy is bearing fruit, and the market begins to re-rate IOI from a commodity planter toward a specialty ingredients company.

Base Case

CPO prices oscillate in the RM3,800-4,500 per tonne range over the next two years, providing a supportive but not exceptional environment for plantation earnings. FFB production grows modestly in FY2026 as guided, partially offset by ongoing Sabah replanting. The plantation segment remains the earnings anchor, generating steady cash flows.

Downstream, the refinery sub-segment muddles along - positive margins when Malaysian CPO duties provide a temporary edge, but structurally challenged against Indonesian competition. The oleochemical sub-segment delivers gradual margin improvement as PKO prices stabilize and IOI progressively shifts its European customer mix toward higher-value pharma and cosmetics derivatives. The recovery is real but slow, with quarterly results showing progress punctuated by occasional setbacks when PKO prices tick up or customer sentiment softens.

Bunge Loders delivers on the Amsterdam Phase 1 commissioning and New Orleans expansion, contributing incrementally to associate earnings. CBE margins remain solid but not exceptional as cocoa butter price volatility makes the specialty fats market lumpy. IOI's new ventures in coconut, palm wood, and EFB pulp are in development and not yet contributing materially.

Management executes the 2025-2029 roadmap steadily but without a dramatic transformation by year three. The business generates consistent cash returns from the plantation and improves its downstream earnings quality over the medium term.

Bear Case

CPO prices fall below RM3,500 per tonne, driven by stronger-than-expected Indonesian production recovery, a global recession reducing edible oil demand, or a further strengthening Malaysian Ringgit reducing RM-denominated price realizations. The plantation segment's earnings fall sharply, eliminating the cash cushion that funds downstream investment.

Simultaneously, the oleochemical recovery stalls. PKO prices spike again as Indonesian biofuel demand for palm kernel distillates increases or a weather event disrupts supply. IOI's European oleochemical margins compress for the third or fourth consecutive year. One or more key pharmaceutical customers in Europe diversify their MCT sourcing following EUDR compliance complications that delay shipments or require expensive supply chain restructuring.

On the regulatory front, a deforestation allegation at one of IOI's third-party supplier mills in Indonesia triggers scrutiny of IOI's EUDR compliance status, threatening European market access for a portion of its oleochemical volumes. Even if resolved, the episode consumes management attention, damages customer relationships, and repeats the pattern of the 2016 RSPO episode - though presumably with less severe impact given IOI's much-improved monitoring infrastructure.

The Bunge Loders Amsterdam plant faces construction delays - not an unusual risk for a €300 million facility - pushing commissioning into 2027 and deferring the associate earnings uplift. The New Orleans expansion is slower to reach full utilization than expected as US confectionery demand softens. IOI's investments in coconut and EFB pulp consume capital without delivering returns on the originally expected timeline.

The result is a multi-year period where the plantation earns below-cycle returns, the downstream fails to compensate as intended, and the new ventures are still pre-revenue or early revenue. IOI's integration advantage, which is supposed to smooth earnings across the commodity cycle, works less well than in theory because all segments face headwinds simultaneously.


Sources: IOI Group Annual Report 2024 | IOI Group Financial Information | IOI Q3 FY2025 Summary Presentation | IOI Q1 FY2026 Summary Presentation | IOI Wikipedia | IOI Oleochemical | IOI Palm Wood | Nextgreen IOI Pulp JV | IOI Five-Year Roadmap | Bunge Loders Amsterdam | Business Today Q2 FY2026 | IOI Corp FY2025 Full Year Earnings | PublicInvest on IOI higher-margin products


Generated by MoatMap on 9 April 2026. Read it online at moatmap.ai/deep-dive/1961.KL; today's score is at moatmap.ai/stock/1961.KL.
IOI Corporation Berhad (1961.KL) Deep Dive - Apr 2026 | MoatMap